EFFECTIVENESS OF COMPLEX TREATMENT FOR RADIOIODINEINDUCED SIALOADENITIS AND ITS EFFECT ON DENTAL HEALTH STATUS OF PATIENTS (PROSPECTIVE CONTROLLED STUDY)
DOI:
https://doi.org/10.35220/2078-8916-2024-51-1.19Keywords:
radioiodine therapy, radiation damage to salivary glands, dental health, dental status, differentiated thyroid cancer, I–131, salivary glands.Abstract
Aim of the study. To study the effectiveness of pathogenetically targeted methods of treatment of chronic radiation sialadenitis caused by the use of radioactive 131I, and their impact on the dental status of patients. Research methods. The study included 60 patients who underwent radioiodine therapy for highly differentiated thyroid carcinoma and developed chronic radiation sialadenitis. Two groups of thirty patients each were formed from the patients. The first group of patients (the control group) received conventional treatment. In the second group (the main group), the treatment of radiation lesions of the salivary glands was based on a developed algorithm of differentiated use of therapeutic agents. This included prolonged glucocorticoids, proteolysis inhibitors, intraductal administration of proteolytic enzymes, the use of sialoendoscopy to eliminate scar changes and persistent stricture of the excretory ducts of the parotid and/or submandibular glands and replacement therapy in the presence of grade II-III xerostomia. Before starting therapy and one year after its initiation, patients underwent a comprehensive examination to determine their clinical characteristics and dental status. Results. At baseline, no significant differences were found between the comparison groups. In 36 patients (60 %), swelling, pain and discomfort were observed mainly in the parotid glands; in 22 patients (36.7 %), these symptoms were bilateral. Clinical signs of damage to all salivary glands were present only in 16 patients (26.7 %). One year after the start of treatment, the patients in both groups demonstrated improved major clinical symptoms, with the main group showing a greater improvement (p<0.05). Significant variability was seen in the parameters of the dental condition of the patients in the comparison groups, which were conditioned by multiple factors unrelated to the prescribed radioactive iodine therapy. There were no statistically significant differences in DMF (decayed, missing, filled teeth) indices, hygiene indices, PMA (papillary-marginal-alveolar) indices or loss of epithelial attachment between the comparison groups, either at the beginning of treatment or after 12 months. Over the course of treatment, the hygiene index tended to get better in both groups, and the severity of gingival inflammation decreased (slightly more in the main group). However, these changes were not statistically significant. Conclusions. When compared to conventional methods of symptomatic and replacement therapy, the developed pathogenetically-targeted approach can reliably reduce the severity of pain, discomfort and swelling of the salivary glands, as well as manifestations of xerostomia (р<0.05). The observed tendency for an improvement in the hygiene index in both groups and a certain decrease in the PMA index (slightly more in the main group) with a slight increase in the DMF index, the depth of periodontal pockets and the loss of epithelial attachment was not statistically significant (p<0.05) due to the small number of observations. The use of conventional methods of individual and professional oral hygiene, combined with replacement therapy, prevented significant progression of caries and periodontal disorders in patients with xerostomia of both examined groups.
References
Auttara-Atthakorn, A., Sungmala, J., Anothaisintawee, T., Reutrakul, S., & Sriphrapradang, C. (2022). Prevention of salivary gland dysfunction in patients treated with radioiodine for differentiated thyroid cancer: A systematic review of randomized controlled trials. Frontiers in endocrinology, 13, 960265. https://doi.org/10.3389/ fendo.2022.960265
Clement S.C., Peeters R.P., Ronckers C.M., Links T.P., van den Heuvel-Eibrink M.M., Nieveen van Dijkum E.J.M., & et al. (2015). Intermediate and longterm adverse effects of radioiodine therapy for differentiated thyroid carcinoma--a systematic review. Cancer Treat Rev. 41(10), 925-34. doi: 10.1016/j.ctrv.2015.09.001.
Caglar M., Tuncel M., & Alpar R. (2002). Scintigraphic evaluation of salivary gland dysfunction in patients with thyroid cancer after radioiodine treatment. Clin Nucl Med. 27(11), 767-71. doi: 10.1097/00003072-200211000- 00003.
Grewal, R. K., Larson, S. M., Pentlow, C. E., Pentlow, K. S., Gonen, M., Qualey, R., & Tuttle, R. M. (2009). Salivary Gland Side Effects Commonly Develop Several Weeks After Initial Radioactive Iodine Ablation. Journal of Nuclear Medicine, 50(10), 1605–1610 doi:10.2967/jnumed.108.061382
Upadhyaya, A., Meng, Z., Wang, P., Zhang, G., Jia, Q., Tan, J., Li, X., Hu, T., Liu, N., Zhou, P., Wang, S., Liu, X., Wang, H., Zhang, C., Zhao, F., & Yan, Z. (2017). Effects of first radioiodine ablation on functions of salivary glands in patients with differentiated thyroid cancer. Medicine, 96(25), e7164. https://doi.org/10.1097/ MD.0000000000007164
La Perle, K.M., Kim, D.C., Hall, N.C., Bobbey, A., Shen, D.H., Nagy, R.S., & Jhiang, S.M. (2013). Modulation of sodium/iodide symporter expression in the salivary gland. Thyroid. 23, 1029–1036. doi: 10.1089/ thy.2012.0571
Walter, M.A., Turtschi, C.P., Schindler, C. & et al. (2007). The dental safety profile of high-dose radioiodine ther- apy for thyroid cancer: Long-term results of a longitudinal cohort study. J Nucl Med., 48, 1620–1625.
Koca, G., Gültekin, S.S., Han, U., Kuru, S., Demirel, K., & Korkmaz, M. (2013) The efficacy of montelukast as a protective agent against 131I-induced salivary gland damage in rats: scintigraphic and histopathological findings. Nucl Med Commun, 34, 507–517. https://doi. org/10.1097/MNM.0b013e32835ffecd
Kim, J.W., Kim, J.M., Choi, M.E., Kim, S.K., Kim, Y.M. & Choi, J.S. (2020) Does salivary function decrease in proportion to radioiodine dose? Laryngoscope, 130(9), 2173–2178 https://doi.org/10. 1002/lary.28342
Tateishi, Y., Sasabe, E., Ueta, E., & Yamamoto, T. (2008) Ionizing irradiation induces apoptotic damage of salivary gland acinar cells via NADPH oxidase 1-dependent superoxide generation. Biochem Biophys Res Commun, 366, 301–307. https://doi.org/ 10.1016/j. bbrc.2007.11.039
Avila, J.L., Grundmann, O., Burd, R., & Limesand, K.H. (2009) Radiation-induced salivary gland dysfunction results from p53-dependent apoptosis. Int J Radiat Oncol Biol Phys, 73, 523– 529. https://doi.org/10.1016/j. ijrobp.2008.09.036
Sadiç, M., Korkmaz, M., Gültekin, S.S., & Demircan, K. (2016) Altera- tions in ADAMTS12 gene expression in salivary glands of radi- oiodine-131-administeredrats. Nucl Med Commun, 37, 1010– 1015. https://doi. org/10.1097/MNM.0000000000000556
Klein Hesselink, E. N., Brouwers, A. H., de Jong, J. R., van der Horst-Schrivers, A. N., Coppes, R.P., Lefrandt, J.D., Jager, P.L., Vissink, A., & Links, T. P. (2016). Effects of Radioiodine Treatment on Salivary Gland Function in Patients with Differentiated Thyroid Carcinoma: A Prospective Study. J Nucl Med, 57(11), 1685-91 http://dx. doi.org/10.2967/jnumed.115.169888
Walter, M.A., Turtschi, C.P., Schindler, C., Minnig, P., Müller-Brand, J., & Müller, B. (2007). The dental safety profile of high-dose radioiodine therapy for thyroid cancer: long-term results of a longitudinal cohort study. J Nucl Med., 48, 1620–1625 doi: 10.2967/ jnumed.107.042192.
Kielbassa, A.M., Hinkelbein, W., Hellwig, E., & Meyer-Luckel, H. (2006). Radiation-related damage to dentition. Lancet Oncol., 7, 326–335.
Stone, H.B., Coleman, C.N., Anscher, M.S., & McBride, W.H. (2003). Effects of radiation on normal tissue: consequences and mechanisms. Lancet Oncol., 4, 529–536.
Mester, A., Piciu, A., Lucaciu, O., Apostu, D., Piciu, D., & Voina-Tonea, A. (2021). Assessment and Care of Oral Lesions for Patients Who Undergo Radioiodine Treatment for Thyroid Cancer. The American journal of the medical sciences, 361(1), 8–13. https://doi.org/10.1016/j. amjms.2020.07.035
Adramerinas, M., Andreadis, D., Vahtsevanos, K., Poulopoulos, A., & Pazaitou-Panayiotou, K. (2021). Sialadenitis as a complication of radioiodine therapy in patients with thyroid cancer: where do we stand? Hormones (Athens), 20(4), 669-678. doi: 10.1007/s42000-021-00304-3
Zeng, Q., & Mandel, L. (2019). Radioactive Iodine-Induced Hyposalivation: Case Report. Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 77(9), 1837–1840 https://doi.org/10.1016/j.joms.2019.03.032
Li, X., Su, J. Z., Zhang, Y. Y., Zhang, L. Q., Zhang, Y. Q., Liu, D. G., & Yu, G. Y. (2020). Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences, 52(3), 586–590 https://doi.org/10.19723/j. issn.1671-167X.2020.03.029
Gilat, H., Vainer, I., Avishai, G., Maymon, S. L., Alkan, U., Hod, R., Robenshtock, E., Friedman, S., & Shpitzer, T. (2021). Radioiodine therapy induced sialadenitis versus chronic idiopathic sialadenitis-Presentation and outcomes. Head & neck, 43(9), 2724–2730. https:// doi.org/10.1002/hed.26741
Sunavala-Dossabhoy, G. (2018). Radioactive iodine: An unappreciated threat to salivary gland function. Oral diseases, 24(1-2), 198–201. https://doi.org/10.1111/ odi.12774
Ciarallo, A., & Rivera, J. (2020). Radioactive Iodine Therapy in Differentiated Thyroid Cancer: 2020 Update. AJR Am J Roentgenol, 215(2), 285-291 doi: 10.2214/ AJR.19.22626. Epub 2020 Jun 17. PMID: 32551904.
Dreyer, N.S., Lynggaard, C.D., Jakobsen, K.K., Pedersen, A.M.L., von Buchwald, C., & Grønhøj, C. (2021). [Xerostomia]. Ugeskr Laeger. Jul 5, 183(27):V11200814. [in Danish].
Łysik, D., Niemirowicz-Laskowska, K., Bucki, R., Tokajuk, G., & Mystkowska, J. (2019). Artificial Saliva: Challenges and Future Perspectives for the Treatment of Xerostomia. Int J Mol Sci., 29, 20(13), 3199. doi: 10.3390/ ijms20133199
Kopchak, A. V., & Makarenko, V. А. (2023). A differentiated approach to complex treatment of radioiodine- induced salivary gland lesions. Modern Medical Technology, 4, 12-20.